Physician profile
Eric M Thorn
NPI 1932240900
$9,208.86
in general payments reported to CMS, 2019-2025
48 companies · $1,390 in 2025
The $1,390 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,192 · 2020: $834 · 2021: $1,013 · 2022: $1,666 · 2023: $1,778 · 2024: $1,336 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,503.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $980.18 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $971.08 | 2019-2025 | |
| Pfizer INC. | $956.85 | 2019-2025 | |
| Amgen INC. | $814.07 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $546.51 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $518.16 | 2020-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $510.43 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $465.47 | 2019-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $389.47 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $367.93 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $341.64 | 2019-2025 | Watchman Access System, Bodyguardian, Varithena Administration Pack |
| Baxter Healthcare | $222.26 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Abbott Laboratories | $204.68 | 2019-2025 | Assurity |
| Irhythm Technologies, INC. | $192.82 | 2019-2023 | Zio Xt Patch |
| Amarin Pharma, INC. | $155.94 | 2019-2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Thorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.